ICDs (implantable cardioverter defibrillators) recalls could eventually have positive effects on US standards of medical device reporting
This article was originally published in Clinica
Executive Summary
The safety issues surrounding Guidant's implantable cardioverter defibrillators (ICDs) could force all device companies to be more open about device faults if the powerful chairman of the Senate finance committee can bring his influence to bear.